EMAS position statement: The essential menopause curriculum for healthcare professionals

The European Menopause and Andropause Society (EMAS) is very proud to announce their new position statement about the essential menopause curriculum for healthcare professionals. It shows that managing perimenopausal and postmenopausal health is a key issue for all areas of healthcare, not just gynecology.   This position statement provides recommendations for the curriculum of education…

Details

Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement

NEW PUBLICATION: EMAS is extremely proud to announce the EMAS 2021 Global Recommendations on Menopause in the Workplace. This will be followed by a Menopause Charter for employers and a Self-Assessment tool for employers and managers. Read more: https://emas-online.org/emas-and-menopause-in-the-workplace-2021 Menopause in the Workplace

Details

EMAS Menopause Essentials

Women’s health is increasingly recognized as a global health priority. Managing perimenopausal and postmenopausal health is a key issue worldwide. Therefore EMAS is making available to all short fact sheets to help women, healthcare and non healthcare professionals understand menopausal health. Read more

Details

Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide

Vulvovaginal atrophy is a chronic condition caused by estrogen deficiency which affects around 50% of postmenopausal women.  EMAS has published a clinical guide on the use of both topical estrogens and non-hormonal lubricants and moisturizers so that treatment can be individualized. Read more https://www.sciencedirect.com/science/article/pii/S037851222100061X

Details

EMAS and IGCS Position statement on managing the menopause after gynecological cancer

February 11, 2020 – European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) Position statement on managing the menopause after gynecological cancer Worldwide, 1.3 million new gynecological cancer cases are diagnosed each year. Treatment can result in loss of ovarian function and, in women under the age of 45, early menopause.  This position…

Details

Management of urinary incontinence in postmenopausal women: an EMAS clinical guide Maturitas 2021; 143: 223–230

30 September 2020 – A new clinical guide by the European Menopause and Andropause Society (EMAS) on the management of urinary incontinence in postmenopausal women is published in Maturitas. Urinary incontinence affects over 1 in 2 women aged over 60 years. The clinical guide provides evidence-based recommendations for the diagnosis and management of this common…

Details

ARCHIVES: VIDEOS

Video Description Genitourinary syndrome of menopause: current and emergent therapies By adminSeptember 21, 2016Leave a commentProf. Faustino Perez-Lopez, Spain Recorded on 21 September 2016 Urinary incontinence and pelvic floor dysfunction By adminJune 22, 2016Leave a commentProf. Tommaso Simoncini, Italy Recorded on 22 June 2016 Screening for breast cancer By adminMay 25, 2016Leave a commentProfessor Herman…

Details

ARCHIVES: VIDEOS

Video Description Women with hysterectomy, premature or early menopause: predictors and health consequences By adminOctober 24, 2017Leave a commentDr. Gita Mishra, Australia Recorded on 24 October 2017   Prevention of frailty in aging By adminSeptember 20, 2017Leave a commentDr. Vincenzo Malafarina, Spain Recorded on 20 September 2017 Menopause and the Metabolic Syndrome By adminJuly 31,…

Details

ARCHIVES: VIDEOS

Video Description Novel cardiovascular disease risk factors for women By adminOctober 16, 2018Leave a commentDr. Chrisandra Shufelt, USA – Recorded on 16 October 2018 Private: Menopausia con elegancia: claves del envejecimiento cutáneo By adminOctober 2, 2018Leave a commentDr. Camil Castelo-Branco, España Grabado el 2 Octubre 2018 Private: Síndrome metabólico y menopausia By adminSeptember 13, 2018Leave…

Details